Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qinwei Chen

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Personalized Medicine|October 23, 2021
Therapeutic Interaction of Apatinib and Chidamide in T-Cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic ApoptosisMengya Zhong, Fusheng Lin, Yuelong Jiang, et al.
Frontiers in Oncology|December 20, 2021
Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular LymphomaMengya Zhong, Jinshui Tan, Guangchao Pan, et al.
Environmental Pollution (Barking, Essex : 1987)|April 13, 2025
Correcting microplastic pollution and risk assessment in Chinese watershedsFeng Yu, Weiwei Yu, Yan Zhao, et al.
European Journal of Pharmacology|November 29, 2021
Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulationLihong Ding, Qinwei Chen, Kai Chen, et al.
European Journal of Pharmacology|November 14, 2018
Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathwayYan Wang, Manman Deng, Qinwei Chen, et al.
Cell Genomics|October 10, 2024
Phenome-wide association study in 25,639 pregnant Chinese women reveals loci associated with maternal comorbidities and child healthJintao Guo, Qiwei Guo, Taoling Zhong, et al.
Cancer Research|July 3, 2021
Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human CancersJintao Guo, Ying Zhou, Chaoqun Xu, et al.
Science Signaling|February 15, 2022
Themis is indispensable for IL-2 and IL-15 signaling in T cellsYongchao Liu, Yu Cong, Yujia Niu, et al.
Biomarker Research|February 7, 2023
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter studyJie Zha, Qinwei Chen, Jingjing Ye, et al.
Biomarker Research|January 3, 2025
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphomaJie Zha, Qinwei Chen, Wei Zhang, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Personalized Medicine|October 23, 2021
Therapeutic Interaction of Apatinib and Chidamide in T-Cell Acute Lymphoblastic Leukemia through Interference with Mitochondria Associated Biogenesis and Intrinsic ApoptosisMengya Zhong, Fusheng Lin, Yuelong Jiang, et al.
Frontiers in Oncology|December 20, 2021
Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular LymphomaMengya Zhong, Jinshui Tan, Guangchao Pan, et al.
Environmental Pollution (Barking, Essex : 1987)|April 13, 2025
Correcting microplastic pollution and risk assessment in Chinese watershedsFeng Yu, Weiwei Yu, Yan Zhao, et al.
European Journal of Pharmacology|November 29, 2021
Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulationLihong Ding, Qinwei Chen, Kai Chen, et al.
European Journal of Pharmacology|November 14, 2018
Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathwayYan Wang, Manman Deng, Qinwei Chen, et al.
Cell Genomics|October 10, 2024
Phenome-wide association study in 25,639 pregnant Chinese women reveals loci associated with maternal comorbidities and child healthJintao Guo, Qiwei Guo, Taoling Zhong, et al.
Cancer Research|July 3, 2021
Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human CancersJintao Guo, Ying Zhou, Chaoqun Xu, et al.
Science Signaling|February 15, 2022
Themis is indispensable for IL-2 and IL-15 signaling in T cellsYongchao Liu, Yu Cong, Yujia Niu, et al.
Biomarker Research|February 7, 2023
Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter studyJie Zha, Qinwei Chen, Jingjing Ye, et al.
Biomarker Research|January 3, 2025
A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphomaJie Zha, Qinwei Chen, Wei Zhang, et al.
Pageof 4